KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.080
+0.020 (0.49%)
Apr 28, 2026, 4:00 PM EDT - Market closed
KORU Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 41.13 | 33.65 | 28.52 | 27.9 | 23.49 | Upgrade
|
| Revenue Growth (YoY) | 22.23% | 17.98% | 2.23% | 18.76% | -2.84% | Upgrade
|
| Cost of Revenue | 15.52 | 12.31 | 11.81 | 12.53 | 9.72 | Upgrade
|
| Gross Profit | 25.6 | 21.33 | 16.71 | 15.37 | 13.77 | Upgrade
|
| Selling, General & Admin | 23.38 | 21.63 | 20.37 | 20.61 | 17.86 | Upgrade
|
| Research & Development | 4.39 | 5.26 | 5.74 | 4.96 | 2.47 | Upgrade
|
| Operating Expenses | 28.58 | 27.78 | 26.98 | 26.15 | 20.8 | Upgrade
|
| Operating Income | -2.97 | -6.45 | -10.27 | -10.78 | -7.03 | Upgrade
|
| Interest & Investment Income | 0.29 | 0.44 | 0.56 | 0.15 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.05 | -0.05 | -0.01 | -0.04 | -0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | -0.02 | - | - | 0.68 | Upgrade
|
| EBT Excluding Unusual Items | -2.62 | -6.06 | -9.71 | -10.68 | -6.37 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.06 | - | 0 | Upgrade
|
| Pretax Income | -2.62 | -6.06 | -9.77 | -10.68 | -6.36 | Upgrade
|
| Income Tax Expense | 0.02 | 0 | 3.97 | -2.01 | -1.8 | Upgrade
|
| Net Income | -2.64 | -6.07 | -13.74 | -8.66 | -4.56 | Upgrade
|
| Net Income to Common | -2.64 | -6.07 | -13.74 | -8.66 | -4.56 | Upgrade
|
| Shares Outstanding (Basic) | 46 | 46 | 46 | 45 | 44 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 46 | 46 | 45 | 44 | Upgrade
|
| Shares Change (YoY) | 0.84% | 0.44% | 1.33% | 1.39% | 5.86% | Upgrade
|
| EPS (Basic) | -0.06 | -0.13 | -0.30 | -0.19 | -0.10 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.13 | -0.30 | -0.19 | -0.10 | Upgrade
|
| Free Cash Flow | -0.47 | -1.62 | -5.68 | -8.17 | -4.67 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.12 | -0.18 | -0.10 | Upgrade
|
| Gross Margin | 62.26% | 63.40% | 58.59% | 55.09% | 58.62% | Upgrade
|
| Operating Margin | -7.23% | -19.16% | -36.01% | -38.65% | -29.93% | Upgrade
|
| Profit Margin | -6.41% | -18.03% | -48.18% | -31.05% | -19.42% | Upgrade
|
| Free Cash Flow Margin | -1.14% | -4.81% | -19.90% | -29.27% | -19.86% | Upgrade
|
| EBITDA | -2.28 | -5.67 | -9.4 | -10.19 | -6.57 | Upgrade
|
| EBITDA Margin | -5.54% | -16.86% | -32.96% | -36.54% | -27.95% | Upgrade
|
| D&A For EBITDA | 0.69 | 0.77 | 0.87 | 0.59 | 0.46 | Upgrade
|
| EBIT | -2.97 | -6.45 | -10.27 | -10.78 | -7.03 | Upgrade
|
| EBIT Margin | -7.23% | -19.16% | -36.01% | -38.65% | -29.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.